Drug survival analysis of dupilumab and associated predictors in patients with atopic dermatitis in South Korea: 4 year, single-center, retrospective study

被引：0
|
作者：
Shin, J. J. [1 ]
Seul, T. W. [1 ]
Park, H. W. [1 ]
Kim, H. Y. [1 ]
Son, S. W. [1 ]
机构：
[1] Korea Univ, Ansan Hosp, Ansan, Gyeonggi Do, South Korea
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
127
引用
收藏
页码：S354 / S354
页数：1
相关论文
共 50 条
  • [31] Clinical Efficacy of a Digital Intervention for Patients with Atopic Dermatitis: a Prospective Single-Center Study
    Sigrídur Lára Gudmundsdóttir
    Tommaso Ballarini
    María L. Ámundadóttir
    Judit Mészáros
    Jenna H. Eysteinsdóttir
    Ragna H. Thorleifsdóttir
    Sigrídur K. Hrafnkelsdóttir
    Heida B. Bragadóttir
    Saemundur Oddsson
    Jonathan I. Silverberg
    Dermatology and Therapy, 2022, 12 : 2601 - 2611
  • [32] Clinical Efficacy of a Digital Intervention for Patients with Atopic Dermatitis: a Prospective Single-Center Study
    Gudmundsdottir, Sigridur Lara
    Ballarini, Tommaso
    Amundadottir, Maria L.
    Meszaros, Judit
    Eysteinsdottir, Jenna H.
    Thorleifsdottir, Ragna H.
    Hrafnkelsdottir, Sigridur K.
    Bragadottir, Heida B.
    Oddsson, Saemundur
    Silverberg, Jonathan, I
    DERMATOLOGY AND THERAPY, 2022, 12 (11) : 2601 - 2611
  • [33] Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis Long-term Results From the Daily Practice BioDay Registry
    Spekhorst, Lotte S.
    de Graaf, Marlies
    Zuithoff, Nicolaas P. A.
    van den Reek, Juul M. P. A.
    Kamsteeg, Marijke
    Boesjes, Celeste M.
    Romeijn, Geertruida L. E.
    Loman, Laura
    Haeck, Inge
    Oosting, Albert J.
    De Boer-Brand, Astrid
    Touwslager, Wouter R. H.
    Flinterman, Annebeth
    Van Lynden-van Nes, Anneke M. T.
    Gostynski, Antoni H.
    de Bruin-Weller, Marjolein S.
    Schuttelaar, Marie-Louise
    JAMA DERMATOLOGY, 2022, 158 (09) : 1048 - 1056
  • [34] SURVIVAL OF ELDERLY HEMODIALYSIS PATIENTS IN THAILAND: RETROSPECTIVE SINGLE-CENTER STUDY
    Srichaichana, Inthira
    Sakulmaiwattana, Nittaya
    Surattichaiyakul, Bongkod
    NEPHROLOGY, 2023, 28 : 69 - 70
  • [35] Long-term drug survival of dupilumab and associated predictors in moderate-to-severe atopic dermatitis: A real-world prospective cohort study
    Pezzolo, Elena
    Rossi, MariaTeresa
    Caroppo, Francesca
    Bianchelli, Tommaso
    Fortina, Anna Belloni
    Giacchetti, Alfredo
    Pinton, Piergiacomo Calzavara
    Naldi, Luigi
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (06) : E757 - E759
  • [36] Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry
    Stoelzl, D.
    Boraczynski, N.
    Heratizadeh, A.
    Haufe, E.
    Harder, I.
    Abraham, S.
    Heinrich, L.
    Kleinheinz, A.
    Wollenberg, A.
    Weisshaar, E.
    Schaekel, K.
    Ertner, K.
    Wiemers, F.
    Wildberger, J.
    Worm, M.
    von Kiedrowski, R.
    Effendy, I.
    Asmussen, A.
    Augustin, M.
    Pawlak, M.
    Sticherling, M.
    Zink, A.
    Hilgers, M.
    Handrick, C.
    Quist, S.
    Schwarz, B.
    Staubach-Renz, P.
    Bell, M.
    Hong-Weldemann, S.
    Homey, B.
    Bruecher, J.
    Schmitt, J.
    Werfel, T.
    Weidinger, S.
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (02) : E39 - E40
  • [37] Four-year long-term drug survival of dupilumab analyzed by treatment period in patients with moderate to severe atopic dermatitis: A real-world retrospective study
    Kang, Da-Hyun
    Kwon, Soon-Hyo
    Lew, Bark-Lynn
    JOURNAL OF DERMATOLOGY, 2024, 51 (03): : e63 - e65
  • [38] Efficacy and Safety of Dupilumab in the Treatment of Refractory Atopic Dermatitis in Older Adults: A Retrospective, Single-Center StudyEfficacy and Safety of Dupilumab in the Treatment of Refractory Atopic DermatitisR. Cai et al.
    Renhui Cai
    Jinwen Huang
    Caifeng Chen
    Zhenjie Ye
    Bo Cheng
    Drugs & Aging, 2025, 42 (4) : 363 - 371
  • [39] Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real-world comparative study
    Torres, Tiago
    Yeung, Jensen
    Prajapati, Vimal
    Ribero, Simone
    Balato, Anna
    Valerio Marzano, Angelo
    Cruz, Maria Joao
    Paiva Lopes, Maria Joao
    Lazaridou, Elizabeth
    Carrascosa, Jose-Manuel
    Alvarenga, Jose Miguel
    Farinha, Pedro
    Duarte, Bruno
    Sood, Siddhartha
    Rankin, Brian D.
    Ortoncelli, Michela
    Caccavale, Stefano
    Ferrucci, Silvia Mariel
    Rosa, Gilberto Pires
    Daponte, Athina Ioanna
    Silvi, Gianmarco
    Peris, Ketty
    Gori, Niccolo
    Herranz, Pedro
    Prignano, Francesca
    Kolios, Antonio
    Rompoti, Natalia
    Gkalpakiotis, Spyridon
    Chiricozzi, Andrea
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025,
  • [40] Drug survival rates and reasons for drug discontinuation in patients with atopic dermatitis: a retrospective study of adult outpatients
    Jehane Pino Lopez
    Christian Kromer
    Raphael Herr
    Astrid Schmieder
    Christiane Bayerl
    Marthe-Lisa Schaarschmidt
    European Journal of Dermatology, 2021, 31 : 233 - 238
12345